Healthcare Trends and Market Dynamics
We invite you to explore our firm’s perspective on the major developments shaping the world of healthcare and the industry leaders orchestrating those transformations. We share firsthand accounts from the entrepreneurs driving these advancements, showcasing their successes and challenges.
In addition to these real-world narratives, our research analysts are fully immersed in identifying the major trends and technological innovations that are driving change across the healthcare spectrum. Our detailed reports break down the complexities of these developments, aiding clients to pinpoint strategic investment opportunities.
Featured Podcasts
Listen in to conversations with industry leaders and innovators that are transforming the future of Healthcare
Can Health Economics Lead to Better Biotech? A Conversation with Rob Abbott
Rob Abbott, CEO of ISPOR, joins Perspectives to talk about why health economics and outcomes research (HEOR) has become more relevant for biotech founders, executives, and investors. The conversation challenges the common perception that HEOR is primarily a post-approval exercise used to support pricing and reimbursement. Instead, Rob discusses how evidence generation, economic modeling, and value strategy can shape clinical development, inform investment decisions, and strengthen the commercial potential of new therapies. The episode concludes with a discussion of ISPOR's Healthcare Investment Summit that will be held in September 2026 and will convene investors, drug developers, and value strategists to translate HEOR into early-stage investment decisions and drug development. Topics discussed include: Two HEOR activities biotech companies should do before Phase III, Four questions investors can ask management teams to gauge commercial opportunity, Novel applications of HEOR and their usefulness for biotech executives and investors, and ISPOR's Healthcare Investment Summit and what biotech leaders and investors might get out of attending.
Featured Research
Explore exclusive insights from our research team that are driving investment opportunities for discerning investors
Recent Articles
Read commentary and analysis from across Leerink Partners on markets, investing, and the Healthcare sector
The Opportunity for Innovation in Desmoid Tumors: A Framework Based on Unmet Need
Benchmarking the Prices of Desmoid Tumor Therapies: A Framework Based on Implied Reimbursement and Health Economic Value
